Complete cytoreductive surgery plus HIPEC for peritoneal metastases from unusual cancer sites of origin: results from a worldwide analysis issue of the Peritoneal Surface Oncology Group International (PSOGI)
Diane Goèré(Assistance Publique – Hôpitaux de Paris), Olivier Gléhen(Hospices Civils de Lyon), Guillaume Passot(Université Claude Bernard Lyon 1), Paul H. Sugarbaker(American Institute for Cancer Research), David L. Bartlett(Allegheny Health Network), Edward A. Levine(Wake Forest University), Maximiliano Gelli(Université Paris-Saclay)
Cited by 78
Related Papers
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.3k
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial
|The Lancet. Gastroenterology & hepatology|2020|602
Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma
|British journal of surgery|2017|255